Clinical Trials Browser

Interventional × Neoplasms × Rifampin × Clear all

NCT02875223 2025-04-20

A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas

Phase 1 Terminated

75 enrolled 35 charts

Lymphoma, Non-Hodgkin, Neoplasms

NCT02197247 2021-07-12

Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC

Phase 1 Completed

41 enrolled 24 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT02706535 2020-11-16

A Cross-over Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics (PK) of GSK525762 in Healthy Female Subjects of Non Child Bearing Potential

Phase 1 Completed

Neoplasms

NCT00207090 2020-11-02

Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer

Phase 1 Completed

19 enrolled 28 charts

Neoplasms

NCT01954043 2017-11-14

A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive Tumors

Phase 1 Completed

Melanoma, Neoplasms

NCT03002493 2017-03-15

To Assess the Effect of Rifampicin on the Pharmacokinetics of Eribulin Mesylate in Participants With Advanced Solid Tumors

Phase 1 Completed

Neoplasms

NCT02836821 2017-02-27

Effect of Rifampicin on the Pharmacokinetics of Apatinib

Phase 1 Completed

Neoplasms

NCT01929603 2017-01-16

Study to Assess the Effect of Rifampicin (CYP Inducer) on Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours

Phase 1 Completed

Neoplasms

NCT01765543 2016-12-15

A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf)

Phase 1 Completed

27 enrolled 16 charts

Melanoma, Neoplasms

NCT00534807 2015-09-01

A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced Cancer

Phase 1 Withdrawn

Neoplasms

NCT01322438 2014-12-19

Effect of Rifampin on the Pharmacokinetics of BAY73-4506

Phase 1 Completed

Neoplasms

NCT01026415 2014-12-18

Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)

Phase 1 Completed

Carcinoma, Hematologic Diseases, Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Neoplasms, Lymphoma, Large-Cell, Anaplastic

NCT01969682 2014-05-26

A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199

Phase 1 Withdrawn

Lymphoma, Non-Hodgkin, Neoplasms, Recurrence